Skip to main content
. 2021 Nov 24;22:302. doi: 10.1186/s12931-021-01871-0

Fig. 1.

Fig. 1

Flowchart of the study. NSCLC non-small cell lung cancer, AIS adenocarcinoma in situ, SNV single nucleotide variants. * In one sample molecular sequencing analysis was already performed in the context of the TSO500 validation trial written by Leonie Kroeze et al. [23]